Paasa Logo
Poolbeg Pharma PLC logo
POLBLSEMarket closedOpens 8:00am UK

Poolbeg Pharma PLC

£0.07Last updated
+£0.00 (0.00%)Past day
Timezone

Poolbeg Pharma PLC (LSE: POLB) is trading at £0.07, about ₹9 at today's GBP/INR rate, as of 30 Sep 2026, 11:35 AM ET. Indian residents can buy Poolbeg Pharma from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:£0.07
Previous close:£0.07
Volume:554.89K

Today's low

£0.07

Today's high

£0.08

52 week low

£0.03

52 week high

£0.10

POLB opened at £0.07, closed previously at £0.07, and has traded between £0.03 and £0.10 over the past 52 weeks.

About

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Country
GB
CEO
Jeremy Skillington
Exchange listed on
LSE
Industry
Biotechnology
Base currency
GBP
Full Time Employees
15
Sector
Healthcare
IPO date
19/07/2021

Key statistics

Avg. volume

3.90M

Market cap

£56.49M

P/E Ratio

-9.49

Price-to-sales ratio

0.00

Enterprise value

£16.39M

Free cash flow yield

-20.08%

Debt-to-equity ratio

0.00

Return on equity

-66.21%

ROIC

-73.60%

Beta

1.83

Dividend yield

0.00%

Last dividend

£0.00

Financial overview

Revenue

£0.00

Earnings per share

-£0.01

Free cash flow

-£4.84M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-£6.36M

Revenue growth

0.00%

Similar securities

This is not an investment recommendation

How to buy Poolbeg Pharma from India

Indian residents can buy Poolbeg Pharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.

  3. Search for Poolbeg Pharma and place an order

    Find Poolbeg Pharma by name or by its ticker, POLB, and choose an order type. Poolbeg Pharma trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Poolbeg Pharma position in GBP and INR. Poolbeg Pharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Poolbeg Pharma from India

Trading and taxes when buying Poolbeg Pharma from India

Trading and limits

Trading hours
8:00 am – 4:30 pm UK
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NonePoolbeg Pharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Transaction tax
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
Estate or inheritance tax
May applyShares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Poolbeg Pharma stock?

Yes. Poolbeg Pharma (POLB) has been listed on the London Stock Exchange since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Poolbeg Pharma share cost in rupees?

One Poolbeg Pharma share is £0.07 — about ₹9 at a GBP/INR rate of 127.06 on 29 Sep 2026. Both the Poolbeg Pharma price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Poolbeg Pharma from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Poolbeg Pharma shares taxed in India?

Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Poolbeg Pharma price. Paasa issues a capital-gains statement for your return.

Does Poolbeg Pharma pay a dividend?

No. Poolbeg Pharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Poolbeg Pharma from India?

The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Poolbeg Pharma shares held from India?

Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. It applies to your overall holdings in that jurisdiction rather than to any one position.

Are there transaction taxes when buying Poolbeg Pharma?

The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.

Do I have to declare Poolbeg Pharma shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Poolbeg Pharma holding, its cost and its closing value.

How do I sell Poolbeg Pharma and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.